Co-delivery of all-trans-retinoic acid enhances the anti-metastasis effect of albumin-bound paclitaxel nanoparticles
- 5 December 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 53 (1) , 212-215
Abstract
Co-delivery of all-trans-retinoic acid and paclitaxel using albumin-bound nanoparticles demonstrated a significantly improved anti-metastatic effect to breast cancer both in vitro and in vivo. Notably, the co-delivery nanoparticles exhibited more pronounced therapeutic effects than the combination of two free drugs or two HSA loaded single drugs.Keywords
This publication has 28 references indexed in Scilit:
- Targeting metastasisNature Reviews Cancer, 2016
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent MannerCancer Research, 2014
- ForewordBiological and Pharmaceutical Bulletin, 2013
- Cancer stem cells and metastasisSeminars in Cancer Biology, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Retinoids, Retinoic Acid Receptors, and CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- Electrochemically deposited metal nanoparticles for enhancing the performance of microfluidic MEMS in biochemical analysisInternational Journal of Nanomanufacturing, 2009
- Albumin-bound paclitaxel: a next-generation taxaneExpert Opinion on Pharmacotherapy, 2006
- Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.Clinical Cancer Research, 2006